Patents by Inventor Fan Daping

Fan Daping has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Apolipoprotein E polypeptides and their use
    Patent number: 10125184
    Abstract: Disclosed herein are several apoplipoprotein E (ApoE) polypeptides, and nucleic acids encoding these polypeptides, that can be used to treat or prevent a hepatitis infection in a subject, such as a hepatitis C virus infection. These ApoE polypeptides can inhibit the entry of hepatitis C virus into cells, and inhibit viral replication. Nucleic acids encoding these polypeptides are also disclosed, as well as methods.
    Type: Grant
    Filed: November 25, 2015
    Date of Patent: November 13, 2018
    Assignees: UNIVERSITY OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION, UNIVERSITY OF SOUTH CAROLINA
    Inventors: Tony Tianyi Wang, Shufeng Liu, Fan Daping
  • APOLIPOPROTEIN E POLYPEPTIDES AND THEIR USE
    Publication number: 20160108104
    Abstract: Disclosed herein are several apoplipoprotein E (ApoE) polypeptides, and nucleic acids encoding these polypeptides, that can be used to treat or prevent a hepatitis infection in a subject, such as a hepatitis C virus infection. These ApoE polypeptides can inhibit the entry of hepatitis C virus into cells, and inhibit viral replication.
    Type: Application
    Filed: November 25, 2015
    Publication date: April 21, 2016
    Applicants: University of Pittsburgh - Of the Commonwealth System of Higher Education, University of South Carolina
    Inventors: Tianyi Wang, Shufeng Liu, Fan Daping
  • Apolipoprotein E polypeptides and their use
    Patent number: 9234026
    Abstract: Disclosed herein are several apoplipoprotein E (ApoE) polypeptides, and nucleic acids encoding these polypeptides, that can be used to treat or prevent a hepatitis infection in a subject, such as a hepatitis C virus infection. These ApoE polypeptides can inhibit the entry of hepatitis C virus into cells, and inhibit viral replication. Nucleic acids encoding these polypeptides are also disclosed, as well as methods for their preparation.
    Type: Grant
    Filed: July 20, 2012
    Date of Patent: January 12, 2016
    Assignees: UNIVERSITY OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION, UNIVERSITY OF SOUTH CAROLINA
    Inventors: Tianyi Wang, Shufeng Liu, Fan Daping
  • APOLIPOPROTEIN E POLYPEPTIDES AND THEIR USE
    Publication number: 20140179595
    Abstract: Disclosed herein are several apoplipoprotein E (ApoE) polypeptides, and nucleic acids encoding these polypeptides, that can be used to treat or prevent a hepatitis infection in a subject, such as a hepatitis C virus infection. These ApoE polypeptides can inhibit the entry of hepatitis C virus into cells, and inhibit viral replication.
    Type: Application
    Filed: July 20, 2012
    Publication date: June 26, 2014
    Applicants: UNIVERSITY OF SOUTH CAROLINA, University of Pittsburgh- Of the Commonwealth System of Higher Education
    Inventors: Tianyi Wang, Shufeng Liu, Fan Daping